Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 18/20 | 0.69 |
| ▸ | PPARD | Q03181 | 18/20 | 0.69 |
| ▸ | PPARA | Q07869 | 17/20 | 0.69 |
| ▸ | ALB | P02768 | 1/20 | 0.62 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.58 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.58 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.58 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6359265 | 0.90 | MEN1 (0.57) | PPARGPPARDPPARAALBAKR1C4 | |
| SCHEMBL6360391 | 0.86 | PPARG (0.66) | PPARGPPARDPPARAALB | |
| SCHEMBL6357153 | 0.79 | ALB (0.83) | PPARGPPARDPPARAALBAKR1C4 | |
| SCHEMBL6357944 | 0.79 | HTR6 (0.68) | PPARGPPARDPPARAAKR1C3AKR1C1 | |
| SCHEMBL6352169 | 0.78 | PPARG (0.55) | PPARGPPARDPPARAALBAKR1C4 | |
| SCHEMBL6349494 | 0.78 | PPARG (0.65) | PPARGPPARDPPARA | |
| SCHEMBL6350433 | 0.78 | PPARG (0.55) | PPARGPPARDPPARAALBAKR1C4 | |
| SCHEMBL6351914 | 0.78 | PPARG (0.65) | PPARGPPARDPPARA | |
| SCHEMBL6352232 | 0.78 | AKR1C2 (0.69) | PPARGPPARDPPARAALBAKR1C4 | |
| SCHEMBL6346566 | 0.77 | ALB (1.00) | PPARGPPARDPPARAALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | claimed |
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | disclosed |
| WO-2004018414-A2 | ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | CLPP, SPOUT1, SAMHD1 | PPARG 3572/4885PPARD 2519/4885PPARA 2335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.